All In Biotech

Drug Trial Radar · NCT05635877

Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients

Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients:A Multicenter, Prospective, Double-blind, Randomized Controlled Study

Last checked: Nov 19, 2026Latest source record: Mar 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 2,000 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,000

Planned (sponsor's estimate)

Start

Feb 7, 2023

Primary completion

Nov 30, 2026

Study completion Dec 30, 2026

Sponsor

Lead sponsor
Yongtao SunAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 2, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 65 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This topic will focus on the following questions: 1. Part one: To clarify the relationship between preoperative frailty and myocardial injury (cTnT ≥0.03) after non-cardiac surgery in elderly patients; To further explore the predictive factors of myocardial injury after non-cardiac surgery (MINS) in elderly frail patients before operation. 2. Part Two: To explore the effect of low-dose esmolol on myocardial injury after non-cardiac surgery in frail elderly patients.

Conditions

  • Frailty
  • Esmolol
  • Myocardial Injury

Interventions

  • EsmololDrug

    The treatment group was given Esmolol 0.5mg/kg load and 10μg /kg/min continuous pump

  • Placebo Comparator: Placebo Comparator:normal saline(0.9%)Drug

    The control group received the same volume of 0.9% normal saline, which was continuously pumped until the end of the operation before extubation.Patient-controlled analgesia pump (sufentanil 2 μg/kg, 2 mL/h, for 48h) was used as the postoperative analgesia regimen in the two groups. If the VAS score was \>3, analgesic adjuvant drugs were given intravenously and recorded. If repeated treatment is ineffective, the study will be excluded.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. incidence of Postoperative myocardial injury after non-cardiac surgery(MINS)Time frame: incidence of MINS within 3 days after operation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University

    Jinan, Shandong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.